SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 2011; 12: 131141.
  • 2
    Patterson RE, Frank LL, Kristal AR, White E. A comprehensive examination of health conditions associated with obesity in older adults. Am J Prev Med 2004; 27: 385390.
  • 3
    Willer CJ, Speliotes EK, Loos RJF et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 2534.
  • 4
    Peng S, Zhu Y, Xu F, Ren X, Li X, Lai M. FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med 2011; 9: 71.
  • 5
    Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889894.
  • 6
    Ahmad T, Chasman DI, Mora S et al. The f-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am Heart J 2007; 160: 11631169.
  • 7
    Okonkwo OC, Cohen RA, Gunstad J, Tremont G, Alosco ML, Poppas A. Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease. Cerebrovasc Dis 2010; 30: 362373.
  • 8
    Bruce DG, Casey GP, Grange V et al. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study. Diabetes Res Clin Pract 2003; 16: 5967.
  • 9
    Ho AJ, Stein JL, Hua X et al. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A 2010; 107: 84048409.
  • 10
    Keller L, Xu W, Wang HX, Winblad B, Fratiglioni L, Graff C. The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study. J Alzheimers Dis 2011; 23: 461469.
  • 11
    Benedict C, Jacobsson JA, Ronnemaa E et al. The fat mass and obesity gene is linked to reduced verbal fluency in overweight and obese elderly men. Neurobiol Aging 2011; 32: 1159. e1–5.
  • 12
    Spreen O, Strauss E. A Compendium of Neuropsychological Tests. New York, NY: Oxford University Press, 1991.
  • 13
    Dikmen S, Heaton R, Grant I, Temkin N. Test-retest reliability of the Expanded Halstead-Reitan Neuropsychological Test Battery. J Int Neuropsychol Soc 1999; 5: 346356.
  • 14
    Wechsler D. Manual for the Wechsler Adult Intelligence Scale, 3rd edn. San Antonio, TX: The Psychological Corporation, 1997.
  • 15
    Delis D, Kramer J, Kaplan E, Ober B. Manual: California Verbal Learning Test, Adult Version. San Antonio, TX: Psychological Corporation, 1987.
  • 16
    Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia, PA: Lea and Febiger, 1983.
  • 17
    Morris JC, Heyman A, Mohs RC et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 11591165.
  • 18
    Hooper H. The Hooper Visual Organization Test. Los Angeles, CA: Western Psychological Services, 1983.
  • 19
    Bressler J, Linda Kao WH, Pankow JS, Boerwinkle E. Risk of type 2 diabetes and obesity is differentially associated with variation in FTO in Whites and African-Americans in the ARIC Study. PLoS One 2010; 5: 18.
  • 20
    Wolk DA, Dickerson BC, Alzheimers Disease Neuroimaging Intiative. Apolipoprotein E (APOE) genotype has dissociable effects on memory on memory and attention-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A 2010; 107: 1025610261.
  • 21
    Persson J, Lind J, Larsson A et al. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology 2006; 66: 10291033.
  • 22
    Gunstad J, Lhotsky A, Wendell CR, Ferrucci L, Zonderman AB. Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. Neuroepidemiology 2010; 34: 222229.
  • 23
    Gustafson D, Lissner L, Bengtsson C, Björkelund C, Skoog I. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004; 63: 1876 1881.
  • 24
    Vogels RL, Oosterman JM, van Harten B et al. Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord 2007; 24: 418423.
  • 25
    Davignon J, Gregg RE, Sing SF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 121.
  • 26
    Kuusi T, Nieminen MS, Ehnholm C et al. Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989; 9: 237241.
  • 27
    van Bockxmeer FM, Mamotte CDS. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet 1992; 340: 879880.
  • 28
    Mielke MM, Leoutsakos JM, Tschanz JT et al. Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's disease. J Alzheimers Dis 2011; 26: 127134.
  • 29
    Peila R, White LR, Ptrovich H et al. Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study. Stroke 2001; 32: 28822889.
  • 30
    Cohen RA. Obesity-associated cognitive decline: excess weight affects more than the waistline. Neuroepidemiology 2010; 34: 230231.
  • 31
    Cohen RA, Gunstad JG, eds. Neuropsychology of Cardiovascular Disease. New York, NY: Oxford University Press, 2010.
  • 32
    Joseph RJ, Alonso-Alonso M, Bonds DS, Pascual-Leone A, Blackburn GL. The neurocognitive connections between physical activity and eating behavior. Obes Rev 2011; 12: 800812.
  • 33
    Lappalainen T, Kolehmainen M, Schwab US et al. Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism – The Finnish Diabetes Prevention Study. Nutr Metab Cardiovasc Dis 2011; 21: 691698.
  • 34
    Peng S, Zhu Y, Xu F et al. FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med 2011; 8: 71.
  • 35
    Liu Y, Liu Z, Song Y et al. Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population. Obesity (Silver Spring) 2010; 18: 16191624.
  • 36
    Ramya K, Radha V, Ghosh S et al. Genetic variations in the FTO gene are associated with type 2 diabetes and obesity in south Indians (CURES-79). Diabetes Technol Ther 2011; 13: 3342.
  • 37
    Kauppi K, Nilsson LG, Adolfsson R. KIBRA polymorphism is related to enhanced memory and elevated hippocampal processing. J Neurosci 2011; 31: 1421814222.